Dr. Burwick will discusses diagnosis and management of thrombotic microangiopathy in pregnancy and the postpartum period. He reviews key differences between HELLP syndrome, TTP, and aHUS. Dr. Burwick focuses on complement-mediated TMA and use of C5 inhibitors for treatment of pregnancy-associated aHUS, with a brief discussion of its investigational use for treatment of preeclampsia, HELLP syndrome and COVID-19 in pregnancy.
